Brief: Rubius Therapeutics Reports First Quarter 2020 Financial Results And Provides Operational Update
11/05/2020 13:44
Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES OPERATIONAL UPDATE
* Q1 LOSS PER SHARE $0.60
* Q1 EARNINGS PER SHARE ESTIMATE $-0.56 -- REFINITIV IBES
DATA
* AS OF MARCH 31, 2020, CASH, CASH EQUIVALENTS AND
INVESTMENTS
WERE $241.4 MILLION
Source text for Eikon: ID:nGNXbtSvVs
Further company coverage: RUBY.O
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft